DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
Costa OS, Connolly SJ, Sharma M. et al.
Andexanet alfa versus four-factor prothrombin complex concentrate for the reversal of apixaban- or rivaroxaban-associated intracranial hemorrhage: a propensity score-overlap weighted analysis.
Crit Care 2022;
26 (01) 180
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.